AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2020
Feb 27, 2020
35124_dirs_2020-02-27_e40d8504-ce84-411e-9934-fa0f328bfc8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2020-02-25
Reporting Person: Tumminello Timothy J (Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-25 | Celsion Corporation Common Stock | A | 14500 | $1.16 | Acquired | 15258 | Direct |
Footnotes
F1: The Filer received Celsion Common Stock as part of their incentive compensation.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18